Probation clients’ barriers to access and use of opioid use disorder medications
Abstract Background There is a gap between evidence-based treatment with medications for opioid use disorders (OUDs) and current practices of probation departments who supervise individuals with OUDs. Many probationers with OUDs cannot access FDA-approved medications to treat their disorders despite...
Main Authors: | Jessica Reichert, Lily Gleicher |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Health & Justice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40352-019-0089-6 |
Similar Items
-
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder
by: Rebecca L. Haffajee, et al.
Published: (2020-09-01) -
Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
by: Koltenyuk V, et al.
Published: (2024-02-01) -
Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost
by: Fatema Z. Ahmed, et al.
Published: (2022-07-01) -
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants
by: Barbara Andraka-Christou, et al.
Published: (2022-08-01) -
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
by: Sharma A, et al.
Published: (2016-04-01)